Production of eukaryotic proteins and nucleic acid molecules in c. elegans
CA 2469135 A1 · Owner: Nexyte Ab · Inventors: Sauer, Uwe H.; Tuck, Simon
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Plasmid vectors for expression in Caenorhabditis elegans harbouring a heat inducible promoter nucleotide sequence a synthetic intron nucleotide sequence optionally containing a Shine-Dalgarno sequence for efficient shuttling between C. elegans and E. coli, optionally a nucleotide sequence coding for a nuclear localisation signal or secretion signal a nucleotide sequence coding , for a recognisable tag optionally a nucleotide sequence coding for a fluorescent protein, a nucleotide sequence coding for a protease cleavage site, a multiple cloning site containing a nucleotide sequence coding for an eukaryotic, such as human, protein or a nucleic acid molecule and a nucleotide sequence …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 26, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 26, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 26, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.